Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biovac OCV-S vs Euvichol-Plus for Cholera Vaccination in South Africa
NCT07304284Phase 3Recruiting
- Sponsor
- International Vaccine Institute
- Start
- Oct 2025
- Primary completion
- Dec 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Biovac OCV-S in cholera, sponsored by International Vaccine Institute. Started Oct 2025; status: recruiting.
02
Drugs
Biovac OCV-S
03
Conditions
cholera
Beyond the preview
Go deeper on NCT07304284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07304284.